ArticleBMC chemistry2024

Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFR

Linxiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.